PARATEK PHARMACEUTICALS INC filings

All
Holdings
Significant ownership
Insider transactions
Annual reports
Quarterly reports
Events
Shareholder votes
SEC filings by PARATEK PHARMACEUTICALS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13D2011-09-28InterWest Partners IX, LPTranscept Pharmaceuticals Inc1,983,88414.7%EDGAR
SC 13D/A2011-07-22New Leaf Ventures I, L.P.Transcept Pharmaceuticals Inc1,140,8088.5%EDGAR
SC 13G/A2011-02-04InterWest Partners IX, LPTranscept Pharmaceuticals Inc1,251,8089.3%EDGAR
SC 13G/A2011-01-03NB Public Equity K/STranscept Pharmaceuticals Inc00.0%EDGAR
SC 13D2010-03-08MONTREUX EQUITY PARTNERS II SBIC LPTranscept Pharmaceuticals Inc554,7064.2%EDGAR
SC 13G/A2010-02-16NB Public Equity K/STranscept Pharmaceuticals Inc838,0166.3%EDGAR
SC 13G2010-02-16InterWest Partners IX, LPTranscept Pharmaceuticals Inc1,251,8089.4%EDGAR
SC 13G/A2010-02-12BIOTECHNOLOGY VALUE FUND L PTranscept Pharmaceuticals Inc00.0%EDGAR
SC 13G/A2010-02-10SOFINNOVA VENTURE PARTNERS V LPTranscept Pharmaceuticals Inc340,7442.6%EDGAR
SC 13D/A2010-02-09PROQUEST INVESTMENTS II LPTranscept Pharmaceuticals Inc00.0%EDGAR
SC 13G/A2010-01-19DOMAIN PARTNERS V LPTranscept Pharmaceuticals Inc--EDGAR
SC 13G2009-10-13NB Public Equity K/STranscept Pharmaceuticals Inc757,6885.8%EDGAR
SC 13G/A2009-02-17ACCIPITER CAPITAL MANAGEMENT, LLCTranscept Pharmaceuticals Inc166,7601.3%EDGAR
SC 13G2009-02-17Versant Affiliates Fund II-A, LPTranscept Pharmaceuticals Inc13,7130.1%EDGAR
SC 13G/A2009-02-13SOFINNOVA VENTURE PARTNERS V LPTranscept Pharmaceuticals Inc2,135,2248.2%EDGAR
SC 13D/A2009-02-09NEW ENTERPRISE ASSOCIATES 10 L PTranscept Pharmaceuticals Inc2,083,42615.9%EDGAR
SC 13D2009-02-09New Leaf Ventures I, L.P.Transcept Pharmaceuticals Inc1,636,98212.5%EDGAR
SC 13G/A2009-01-16BIOTECHNOLOGY VALUE FUND L PNOVACEA INC341,2711.3%EDGAR
SC 13G2008-12-12SCHERING CORPNOVACEA INC1,490,8685.8%EDGAR
SC 13D/A2008-09-29NEW ENTERPRISE ASSOCIATES 10 L PNOVACEA INC--EDGAR
External links